| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.037 | 0.8 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.8 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | AMG-706 | FIMM | pan-cancer | AAC | -0.033 | 0.8 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.8 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.0066 | 0.8 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.0064 | 0.8 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |